PATENT CLAIM ANALYSIS

Application Number: 15751547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["562", "030000"]

Abstract:
Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.

Claim (Index 13):
The compound of  claim 11 , wherein:\n R a1  is selected from hydrogen, \u2014(CH 2 ) 2 \u2014C(O)OH, \u2014(CH 2 ) 2 \u2014C(O)O\u2014CH 3  and \u2014C(O)\u2014[CH(R A )] 1-2 \u2014NH\u2014R B ; each R A , if present, is selected from \u2014CH 3 , \u2014CH 2 OH, \u2014(CH 2 ) 4 \u2014NH 2 , \u2014CH 2 \u2014CH(CH 3 ) 2 , \u2014(CH 2 ) 2 \u2014S(O) 2 \u2014CH 3 , \u2014CH 2 \u2014C(O)\u2014NH 2 , \u2014CH 2 \u2014C(O)OH, \u2014CH(CH 3 )OH, \u2014CH(CH 3 ) 2 , benzyl, 1H-imidazol-4-yl-methyl, 4-hydroxybenzyl, and 1H-indolyl-3-ylmethyl; and R B  is selected from hydrogen and Cbz.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.04762
- Patent Class: 562.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16320589', '14769421', '10307735', '15740462', '15312614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7591419335785387
- 35 USC 102 Novelty (BERT): 0.5308510950285735
- Combined Prediction Score: 0.7363128497235422
- Mean Citation Score: 338.91286
- Max Citation Score: 342.17654
- Similarity Product: 248.214729823854

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test